CVRx (CVRX) Other financing activities (2021 - 2026)

CVRx (CVRX) posted quarterly Other financing activities of $32000.0 for Q1 2026, down 92.61% quarter-over-quarter from $433000.0 in Q4 2025.

CVRx (CVRX) Other financing activities (2021 - 2026) Analysis & Trends

CVRx's Other financing activities history runs 6 years deep, the most recent figure standing at $32000.0 for Q1 2026.

In Q1 2026, Other financing activities changed N/A year-over-year to $32000.0; the TTM figure through Mar 2026 stood at $825000.0 (up 224.43% YoY), while the FY2025 annual figure was $793000.0, up 421.71% from the prior year.
Other financing activities for Q1 2026 stood at $32000.0, down from $433000.0 in the prior quarter.
The five-year high for Other financing activities was $815000.0 in Q1 2024, with the low at -$732000.0 in Q3 2024.
The 5-year median for Other financing activities is $96000.0 (2023), against an average of $152800.0.
The sharpest annual moves came in 2022 and 2025: Other financing activities slumped 2300.0% in 2022, then surged 21550.0% in 2025.
CVRx's Other financing activities stood at $292000.0 in 2022, then decreased by 5.48% to $276000.0 in 2023, then tumbled by 99.28% to $2000.0 in 2024, then soared by 21550.0% to $433000.0 in 2025, then tumbled by 92.61% to $32000.0 in 2026.
Business Quant data shows CVRX's Other financing activities at $32000.0 in Q1 2026, $433000.0 in Q4 2025, and $360000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	CVRx	74.38 Mn	9.79 Mn	13.72 Mn

Download Data